Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

Christine Sekaggya-Wiltshire, Kelly Elise Dooley

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)615-618
Number of pages4
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume15
Issue number8
DOIs
StatePublished - Aug 3 2019

Fingerprint

Rifamycins
Pharmacodynamics
Pharmacokinetics
Tuberculosis
Anti-Bacterial Agents
rifamycin SV

Keywords

  • pharmacodynamics
  • pharmacokinetics
  • Rifamycins
  • tuberculosis

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis. / Sekaggya-Wiltshire, Christine; Dooley, Kelly Elise.

In: Expert Opinion on Drug Metabolism and Toxicology, Vol. 15, No. 8, 03.08.2019, p. 615-618.

Research output: Contribution to journalEditorial

@article{db891f6153ca4e918f4f6f685849eb6d,
title = "Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis",
keywords = "pharmacodynamics, pharmacokinetics, Rifamycins, tuberculosis",
author = "Christine Sekaggya-Wiltshire and Dooley, {Kelly Elise}",
year = "2019",
month = "8",
day = "3",
doi = "10.1080/17425255.2019.1648432",
language = "English (US)",
volume = "15",
pages = "615--618",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

AU - Sekaggya-Wiltshire, Christine

AU - Dooley, Kelly Elise

PY - 2019/8/3

Y1 - 2019/8/3

KW - pharmacodynamics

KW - pharmacokinetics

KW - Rifamycins

KW - tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85070253786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070253786&partnerID=8YFLogxK

U2 - 10.1080/17425255.2019.1648432

DO - 10.1080/17425255.2019.1648432

M3 - Editorial

C2 - 31339806

AN - SCOPUS:85070253786

VL - 15

SP - 615

EP - 618

JO - Expert Opinion on Drug Metabolism and Toxicology

JF - Expert Opinion on Drug Metabolism and Toxicology

SN - 1742-5255

IS - 8

ER -